Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
Current Portion of Long-Term Debt
Edwards Lifesciences Corp
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Edwards Lifesciences Corp
NYSE:EW
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Current Portion of Long-Term Debt
$1.1B
|
CAGR 3-Years
337%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
75%
|
|
Stryker Corp
NYSE:SYK
|
Current Portion of Long-Term Debt
$2.1B
|
CAGR 3-Years
416%
|
CAGR 5-Years
32%
|
CAGR 10-Years
10%
|
|
Abbott Laboratories
NYSE:ABT
|
Current Portion of Long-Term Debt
$2B
|
CAGR 3-Years
39%
|
CAGR 5-Years
202%
|
CAGR 10-Years
74%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|